2005
DOI: 10.1016/j.jaad.2004.04.008
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation and treatment of male and female pattern hair loss

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
209
0
15

Year Published

2012
2012
2024
2024

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 231 publications
(224 citation statements)
references
References 62 publications
0
209
0
15
Order By: Relevance
“…By contrast, so-called female patterned alopecia may be truly 'androgenetic' for only a small number of women with thinning hair, and so other age-associated alopecias in women are likely to have other causes. 97 Regardless of cause, age-related alopecia affects at least 50% of men by the age of 50 years and 50% of women by the age of 60 years. 98 White hair was thicker on average, showed more medulla 99,100 and grew faster than pigmented hair.…”
Section: Hairmentioning
confidence: 99%
“…By contrast, so-called female patterned alopecia may be truly 'androgenetic' for only a small number of women with thinning hair, and so other age-associated alopecias in women are likely to have other causes. 97 Regardless of cause, age-related alopecia affects at least 50% of men by the age of 50 years and 50% of women by the age of 60 years. 98 White hair was thicker on average, showed more medulla 99,100 and grew faster than pigmented hair.…”
Section: Hairmentioning
confidence: 99%
“…The only additional risk of the 5% topical minoxidil solution over the 2% topical minoxidil solution reported was the higher incidence of facial hypertrichosis [9].…”
Section: Minoxidilmentioning
confidence: 99%
“…The frequency and severity of this type of hair loss increases with age [5]. It usually appears in the third and fourth decades and affects 30% to 50% of men by the age of 50 and around 80% of caucasian men aged over 70 years [1,2,[6][7][8][9].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…그 중 미녹시딜은 먹는 발모제인 finasteride와 함께 미 국 FDA 승인을 받은 효능이 검증된 바르는 발모제이다. 12,13 미녹시딜은 투여 용량 등에 따라서 홍반, 피부염, 빈맥을 포 함한 다양한 형태의 부작용이 발생될 가능성이 있다. 14 …”
Section: 서 론unclassified